medigraphic.com
SPANISH

Revista Médica MD

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 2

<< Back Next >>

Rev Med MD 2012; 3.4 (2)

Malignant Bone Tumors of the Thoracic Wall in Pediatric Patients, Treatment Experience

Gutiérrez-Ureña JA , González-Valdez JA , Ramírez-Urenda XA , Orozco-Pérez J , Trujillo-Ponce SA , Aguirre-Jáuregui O , Erro-Aboytia R
Full text How to cite this article

Language: Spanish
References: 14
Page: 91-96
PDF size: 632.56 Kb.


Key words:

block tumor resection, bone tumors, Ewing sarcoma, neoadjuvant chemotherapy, osteosarcoma, radiotherapy, thoracic wall.

ABSTRACT

Introduction: Bone tumors of the thoracic wall are infrequent in the pediatric population, but in most cases are malignant, being Ewing sarcoma the most prevalent. Malignant tumors of the thoracic wall tend to be aggressive, and require multidisciplinary and comprehensive treatment.
Material and Methods: A prospective, descriptive study of case series was designed including patients diagnosed with primary thoracic wall bone tumors from January 2006 through September 2012. Variables such as: clinical findings, histology, location of the tumor, medical and surgical treatment, complications and current health state were analyzed.
Results: A total of seven patients between the ages of 10 months and 15 years were included (mean age 7.7 years). Most frequent clinical findings were: pain and deformity of the thoracic wall in all seven patients (100 %). In all seven patients osteoblastic and osteolitic lesions were found in chest x-rays, two patients presented pleural effusion (28.5%). Osteolitic lesions were demonstrated by CT scan as well as hot spots in bone scintigraphy (MDP technetium 99m) in 100% of patients. Histopathology reports concluded Ewing sarcoma in five patients (71.45%) and osteosarcoma in two cases (28.6%). Regarding treatment, all patients received neoadjuvant chemotherapy. The surgical procedure used was block tumor resection with disease free margins of 1 to 5 cm. Reconstruction was performed using a polypropylene mesh. All patients received adjuvant chemotherapy, and five of them radiotherapy. Average follow up was 29.5 months. Tumor reappearance was documented in three patients, in these patients, disease free margins were shorter than 1 cm. currently, four patients are still alive (57.2%), three of them with no active tumor. Survival rate is 57.2 and disease free rate 42.8%.
Discussion: Thoracic wall bone tumors are rare and display an aggressive behavior, treatment should be multimodal and completely coordinated. Block tumor resection surgery with wide disease - free margins has the most important prognostic survival rate for patients affected with this disease.


REFERENCES

  1. 1.- Larsson SE, Lorentzon R. The incidence of malignant prumary bone tumors in relation to age, sex and site. A study of osteogenic sarcoma, condrosarcoma and Ewing sarcoma diagnosed in Swedan from 1958 to 1968. J Bone Joint Surg Br. 1974 Aug;56B(3):534-40.

  2. 2.- Sendia K, Sang L, Danielle A. A, Robbert A.M.S, Robert C.S, Mark P. Pediatrics ribs lesions: a 13 tear experience. J Pediatr Surg. 2008 Oct;43(10):1781-5.

  3. 3.- Shamberger RC, Grier HE, Chest wall tumors in infants and children. Semin Pediatr Surg. 1994 Nov;3(4):267-76.

  4. 4.- Marco-Rojas G, Laín-González A. Tumores De pared torácica. Rev Chilena de Cirugía. 2004;56(2):182- 184.

  5. 5.- Wong KS, Hung IJ, Wang CR, Lien R.Thoracic wall lesion in children. Pediatr Pulmonol. 2004 Mar;37(3):257-63.

  6. 6.- Askin FB, Rosai J, Sibley RK, Dehner LP, McAlister WH . Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopatologic entity of uncertain histogenesis. Cancer. 1979 Jun;43(6):2438-51.

  7. 7.- vanden Berg H , van Rijn RR , Merks JH.Management of tumors of the chest wall in childhood: A review. J Pediatr Hematol Oncol. 2008 Mar;30(3):214-21.

  8. 8.- Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, et al. Addition of ifosfamida and etoposide to standarth chemofherapy for Ewings sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003 Feb 20;348(8):694-701.

  9. 9.- Schuck A, Ahrens S, Konarzewska A, Paulussen M, Fröhlich B, Könemann S, et al. Hemithorax irradiation for Ewing tumors of the chest wall. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):830-8.

  10. -Shamberger RC, Laquaglia MP, Krailo MD, Miser JS, Pritchard DJ, Gebhardt MC,et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61.

  11. 11.- Shamberger RC, LaQuaglia MP, Gebhardt MC, Neff JR, Tarbell NJ, Marcus KC, et al. Ewing Sarcoma/ Primitive Neuroectodermal Tumor of The Chest Wall. Impact of Initial Versus Delayed Resection on Tumor Margins Survival, and Use of Radiation Therapy. Ann Surg. 2003 Oct;238(4):563- 7;

  12. - Yamaguchi T, Shimizu K, Koguichi Y, Soatome K, Ueda Y. Low-grade Central Osteosarcoma of the Rib. Skeletal Radiol. 2005 Aug;34(8):490-3.

  13. 13.- Wyttenbach R, Vock P, Tschappeler H. Crosssectional imagin with CT and/or MRI of pediatric chest tumors. Eur Radiol. 1998;8(6):1040-6.

  14. 14.- Donnelly LF, Frush DP, Foss JN, O'Hara SM, Bisset GS 3rd.Anterior chest wall: frequency of anatomic variations in children. Radiology. 1999 Sep;212(3):837-40.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med MD. 2012;3.4